Addition  Technology, Inc., a privately held eye care company, specializes in novel  solutions for sight-threatening eye indications.

Intacs® and Intacs SK corneal implants and the AlphaCor™ artificial cornea are patented devices, and  the first of their kind, cleared by the FDA and granted CE Mark certification  in Europe in addressing vision threatening  conditions of the cornea.  Intacs corneal  implants are indicated for keratoconus and myopia.

AlphaCor™ artificial cornea is indicated as an  alternative for high-risk, repeat graft failures.

The AlphaSphere™ orbital implant, which  has FDA approval, has been developed utilizing a “state of the art”  patented design and an advanced  bio-integratable, medically proven material which will make orbital implant  surgery easier and provide more natural movement.

Addition Technology distributes its products through highly skilled employees and an international distributor network.

For more information, please view this website and visit: www.IntacsForKeratoconus.com and www.AlphaCor-ati.com.